Site navigation

Navigation

Smoking cessation - bupropion and nicotine replacement therapy (replaced by PH10)

The clinical effectiveness and cost effectiveness of bupropion (Zyban) and Nicotine Replacement Therapy for smoking cessation

Summary

This guidance has been replaced by PH10 Smoking cessation services


Guidance documents

  • No documents found

Implementing this guidance

  • None available

Other information

About this guidance

Technology appraisals TA39

Issued: March 2002

How this guidance was produced

See also:

See this guidance in practice:

Order printed copies of this guidance